Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Revenue 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Catalyst Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 149.4 M, a 5.63% increase year-over-year.
- Catalyst Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 585.8 M, a 29.42% increase year-over-year.
- Catalyst Pharmaceuticals Inc. annual revenue for 2025 was 589.0 M, a 19.78% increase from 2024.
- Catalyst Pharmaceuticals Inc. annual revenue for 2024 was 491.7 M, a 23.49% increase from 2023.
- Catalyst Pharmaceuticals Inc. annual revenue for 2023 was 398.2 M, a 85.90% increase from 2022.
- Catalyst Pharmaceuticals Inc. annual revenue for 2022 was 214.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Catalyst Pharmaceuticals Inc. Revenue — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) revenue over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Catalyst Pharmaceuticals Inc.'s revenue?
Catalyst Pharmaceuticals Inc. (CPRX) reported revenue of $589M for fiscal 2025.
Where can I see CPRX's revenue history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.